ARCHIVES

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

This article is from The Cancer Letter archive.

Vol. 11 No. 05 | February 1, 1985

Download PDF Visit The Full Archive

Related Articles

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

FDA Throws Up IND Roadblock, Then Refuses To Answer Investigator’s Letters About It

February 6, 1976

Tivozanib Does Not Improve OS Compared to Sorafenib

February 22, 2013

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012